Incretin & Metabolic Receptor Agonists
Semaglutide
Also known as Ozempic · Wegovy · Rybelsus
FDA-approved for specific indicationsFDA-approved
Last reviewed: 2026-11-19
History
Novo Nordisk researchers including Jesper Lau and colleagues published its discovery in 2015; initial FDA approval followed in 2017.
Key sources
Targeted factual corrections checked against the sources below on November 19, 2026. This is not an exhaustive systematic review; discovery dates, exact molecular forms and current labels require separate verification.
Related compounds
- Retatrutide
Same scientific class · A 39-amino-acid chain. · Late-stage human trials
- Tirzepatide
Same scientific class · A 39-amino-acid chain. · FDA-approved for specific indications